Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
0
Number of overlapping holdings
0.0%
% of IDNA's 51 holdings also in XDNA
nan%
% of XDNA's 3 holdings also in IDNA
Overlap by Weight
Sector Drift (IDNA minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IDNA |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
Position Highlights (Non-Overlapping Exposures)
IDNA Overweight Relative to XDNA
 |
BEIGENE, LTD. | 5.9% |
 |
SANOFI-AVENTIS | 5.5% |
 |
GSK PLC | 5.4% |
 |
ROCHE HOLDING LTD | 5.4% |
 |
EXELIXIS INC | 5.3% |
|
ASTRAZENECA PLC | 5.1% |
 |
TAKEDA PHARMACEUTICAL CO LTD | 5.0% |
|
SPRINGWORKS THERAPEUTICS, INC. | 4.8% |
 |
GENMAB A/S | 4.7% |
 |
BIONTECH SE SPONSORED ADR | 4.1% |
IDNA Underweight Relative to XDNA
|
INTELLIA THERAPEUTICS, INC. | 0.1% |
|
BEAM THERAPEUTICS, INC. | 0.2% |
|
LIGAND PHARMACEUTICALS-CL B | 0.2% |
|
CARGO THERAPEUTICS, INC. | 0.2% |
|
SANGAMO BIOSCIENCES INC | 0.2% |
|
4D MOLECULAR THERAPEUTICS, INC. | 0.2% |
 |
OMNIAB, INC. | 0.3% |
|
CRISPR THERAPEUTICS AG | 0.3% |
|
ORIC PHARMACEUTICALS INC | 0.4% |
|
ALLOGENE THERAPEUTICS, INC. | 0.4% |